Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY:ZBH)

90.89 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
Q2 Earnings Review: Surgical Equipment & Consumables - Diversified Stocks Led by Zimmer Biomet (NYSE:ZBH)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
The Dawn of a New Era: How GLP-1s, AI, and Robotic Surgery Are Reshaping Healthcare and Investment
The healthcare industry is currently experiencing a transformative "golden age," a period marked by an unprecedented surge in scientific breakthroughs and technological advancements. This era is... 
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Economy
News headline image
Surgical Equipment & Consumables - Diversified Stocks Q2 Highlights: STERIS (NYSE:STE)
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including STERIS (NYSE:STE) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Earnings Scheduled For August 7, 2025 ↗
 
Via Benzinga
News headline image
What Does the Market Think About Zimmer Biomet Holdings? ↗
 
Via Benzinga
News headline image
1 Unpopular Stock That Deserves a Second Chance and 2 That Underwhelm
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
News headline image
Surgical Equipment & Consumables - Diversified Stocks Q2 Teardown: Solventum (NYSE:SOLV) Vs The Rest
Let’s dig into the relative performance of Solventum (NYSE:SOLV) and its peers as we unravel the now-completed Q2 surgical equipment & consumables - diversified earnings season. 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 Mid-Cap Stocks Walking a Fine Line
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
Topics Economy
News headline image
Surgical Equipment & Consumables - Diversified Stocks Q2 Results: Benchmarking BD (NYSE:BDX)
Let’s dig into the relative performance of BD (NYSE:BDX) and its peers as we unravel the now-completed Q2 surgical equipment & consumables - diversified earnings season. 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
P/E Ratio Insights for Zimmer Biomet Holdings ↗
 
Via Benzinga
News headline image
Looking Into Zimmer Biomet Holdings's Recent Short Interest ↗
 
Via Benzinga
News headline image
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever ↗
Dip into a beaten-down market sector for deals on some proven winners. 
Via The Motley Fool
News headline image
ZBH Q2 Deep Dive: New Product Launches and M&A Drive Guidance Upgrades
Medical device company Zimmer Biomet (NYSE:ZBH) announced better-than-expected revenue in Q2 CY2025, with sales up 7% year on year to $2.08 billion. Its non-GAAP profit of $2.07 per share was 4.8%... 
Via StockStory
Topics World Trade
News headline image
A Glimpse Into The Expert Outlook On Zimmer Biomet Holdings Through 5 Analysts ↗
 
Via Benzinga
News headline image
Stay informed with the top movers within the S&P500 index on Thursday. ↗
Let's delve into the developments on the US markets one hour before the close of the markets on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Zimmer Biomet (NYSE:ZBH) Exceeds Q2 Expectations, Stock Soars
Medical device company Zimmer Biomet (NYSE:ZBH) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7% year on year to $2.08 billion. Its non-GAAP profit of $2.07 per share was 4.8%... 
Via StockStory
News headline image
Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook ↗
Zimmer Biomet beat Q2 estimates and raised its 2025 earnings forecast, driven by strong hip and knee sales, and new product momentum. 
Via Benzinga
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
News headline image
Thursday's session: gap up and gap down stock in the S&P500 index ↗
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
Via Chartmill
News headline image
Zimmer Biomet (ZBH) Q2 Revenue Jumps 7% ↗
Via The Motley Fool
Topics Economy
News headline image
Zimmer Biomet (ZBH) Q2 Earnings: What To Expect
Medical device company Zimmer Biomet (NYSE:ZBH) will be reporting earnings this Thursday before the bell. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence Government World Trade
News headline image
Zimmer Biomet Holdings Inc (NYSE:ZBH): A Steady Dividend Performer with Strong Profitability and Financial Stability ↗
Zimmer Biomet (ZBH) offers steady dividends with 10+ years of payouts, strong profitability, and financial health, making it a reliable pick for long-term dividend investors. 
Via Chartmill
News headline image
Monogram Technologies Announces World’s First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery
From Monogram Technologies Inc.
Via GlobeNewswire
News headline image
Zimmer Biomet Holdings Inc (NYSE:ZBH): A Prime Value Investing Opportunity with Strong Fundamentals and Undervalued Metrics ↗
Zimmer Biomet (ZBH) is a top value stock with strong profitability, low P/E ratios, and solid financial health—ideal for investors seeking undervalued healthcare opportunities. 
Via Chartmill
News headline image
ZimVie Doubles — And Then Some — On Its Second Takeover Deal ↗
The Zimmer Biomet spinoff is looking to head for private waters under the fund Archimed. 
Via Investor's Business Daily
News headline image
Get insights into the top movers in the S&P500 index of Tuesday's pre-market session. ↗
Discover the top S&P500 movers in Tuesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Monogram Technologies Inc. (Nasdaq - MGRM), Veritex Holdings, Inc. (Nasdaq - VBTX), ESSA Pharma Inc. (Nasdaq - EPIX), Waters Corporation (NYSE - WAT)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Zimmer Biomet To Lead Orthopedic Robotics With Monogram's AI Tech ↗
Zimmer Biomet plans to acquire Monogram and integrate its robotic knee system into its ROSA platform to support growth and product expansion through 2027. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Boeing, Uber, Delta Air Lines And A Health Care Stock On CNBC's 'Final Trades' ↗
Stephanie Link, chief investment strategist and portfolio manager at Hightower, picked The Boeing Company as her final trade. 
Via Benzinga
News headline image
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions
From Monogram Technologies Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.